Article

Laparoscopic treatment of Crohn's disease.

Department of Surgery, University of Chicago Pritzker Medical School, MC 5095, 5841 South Maryland Avenue, Chicago, IL 60637, USA.
World Journal of Surgery (impact factor: 2.36). 03/2011; 35(7):1500-4. DOI:10.1007/s00268-011-1031-9 pp.1500-4
Source: PubMed

ABSTRACT The surgical and medical management of inflammatory bowel disease (IBD) has significantly evolved over the course of the last two decades. On the medical side, the introduction of biologic therapy has significantly changed the characteristics of the patients undergoing surgery for Crohn's disease (CD), while its impact on the need for surgical intervention and the surgical outcomes of these patients is still debated. On the surgical side, the introduction of and the growing experience with minimally invasive approaches to IBD have had a significant impact on outcomes and quality of life in this patient population. During the past three decades the evidence has been accumulating in favor of a minimally invasive approach to CD. Clearly, this is probably one of the most challenging diseases to treat laparoscopically for the colorectal surgeon, especially when the disease is located in the colon and involves multiple segments.

0 0
 · 
0 Bookmarks
 · 
37 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

biologic therapy
 
challenging diseases
 
characteristics
 
colorectal surgeon
 
growing experience
 
IBD
 
medical management
 
medical side
 
multiple segments
 
patient population
 
patients
 
patients undergoing surgery
 
significant impact
 
surgical
 
surgical intervention
 
surgical outcomes
 
surgical side
 
three decades
 

Alessandro Fichera